Mutant mice in which tyrosine at position 136 of LAT is replaced with phenylalanine (LatY136F mice) develop a lymphoproliferative disorder involving CD4+ T cell effectors that trigger systemic autoimmunity (Aguado et al., 2002). Here, LAT is linked to lymphoproliferative syndrome.